Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon.

Asthma research and practice Pub Date : 2017-11-21 eCollection Date: 2017-01-01 DOI:10.1186/s40733-017-0036-z
Rachel Tan, Biljana Cvetkovski, Vicky Kritikos, David Price, Kwok Yan, Pete Smith, Sinthia Bosnic-Anticevich
{"title":"Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon.","authors":"Rachel Tan,&nbsp;Biljana Cvetkovski,&nbsp;Vicky Kritikos,&nbsp;David Price,&nbsp;Kwok Yan,&nbsp;Pete Smith,&nbsp;Sinthia Bosnic-Anticevich","doi":"10.1186/s40733-017-0036-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention.</p><p><strong>Methods: </strong>Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms.</p><p><strong>Results: </strong>Of the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor's diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers' perceptions of medication effectiveness (47.6%).</p><p><strong>Conclusion: </strong>A majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner.</p>","PeriodicalId":8572,"journal":{"name":"Asthma research and practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40733-017-0036-z","citationCount":"42","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asthma research and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40733-017-0036-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 42

Abstract

Background: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing allergic rhinitis patients is the community pharmacy. With the majority of allergic rhinitis treatments being available for purchase over the counter, without health care professional contact, we know little about how the patients self-manage. This study aims to identify the burden of allergic rhinitis in the community pharmacy and to identify key opportunity for intervention.

Methods: Pharmacy customers, who purchased nasal treatment in a community pharmacy, were approached with a research-administered questionnaire that collected data on medical history, symptoms and products purchased for the treatment of nasal symptoms.

Results: Of the 296 participants, 69.9% self-managed with over-the-counter medications; with 68% experiencing allergic rhinitis symptoms and only 44.3% of this subgroup had a doctor's diagnosis. Nasal congestion (73.6%) was most commonly experienced and oral antihistamines were most commonly purchased (44.3%), indicating a pattern of suboptimal management. A third of participants (36.5%) experienced moderate-severe symptoms, persistently, which impacted on their daily living. Medication selection was mainly based on pharmacy customers' perceptions of medication effectiveness (47.6%).

Conclusion: A majority of participants that self-selected over-the-counter medications have symptoms consistent with allergic rhinitis, with almost half not having received a diagnosis. Medication purchasing patterns suggest that sub-optimal therapeutic decisions made by participants, even when they are experiencing significant symptoms. This study uncovers the hidden burden of allergic rhinitis in the community pharmacy and a missed opportunity to intervene and refer if necessary. Patients need to be guided through appropriate treatment as this study showed that many should be referred to a medical practitioner.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
识别社区药房变应性鼻炎(AR)的隐性负担:一个全球现象。
背景:变应性鼻炎患者往往轻视自己的病情,自我管理不当,并将受益于卫生保健干预。这些自我管理过敏性鼻炎患者的主要卫生保健接触点是社区药房。由于大多数过敏性鼻炎治疗可以在柜台购买,没有医疗保健专业人员联系,我们对患者如何自我管理知之甚少。本研究旨在确定变应性鼻炎在社区药房的负担,并确定关键的干预机会。方法:对在社区药房购买鼻腔治疗的药房顾客进行问卷调查,收集病史、症状和购买治疗鼻腔症状的产品的数据。结果:在296名参与者中,69.9%的人使用非处方药进行自我管理;68%的人有过敏性鼻炎症状,只有44.3%的人得到了医生的诊断。最常见的是鼻塞(73.6%),最常见的是购买口服抗组胺药(44.3%),表明管理模式不理想。三分之一的参与者(36.5%)持续出现中重度症状,影响了他们的日常生活。药物选择主要基于药房顾客对药物有效性的感知(47.6%)。结论:大多数自行选择非处方药的参与者有与过敏性鼻炎一致的症状,几乎一半的人没有接受过诊断。药物购买模式表明,参与者做出的次优治疗决定,即使他们经历了显著的症状。本研究揭示了变应性鼻炎在社区药房的隐性负担,并错过了必要时进行干预和转诊的机会。患者需要通过适当的治疗指导,因为这项研究表明,许多人应该转介到医生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
6
审稿时长
20 weeks
期刊介绍: Asthma Research and Practice is the official publication of Interasma and publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research. Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.
期刊最新文献
Psychological distress and associated factors among asthmatic patients in Southern, Ethiopia, 2021. Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use. Nonadherence to antiasthmatic medications and its predictors among asthmatic patients in public hospitals of Bahir Dar City, North West Ethiopia: using ASK-12 tool. The hen and the egg question in atopic dermatitis: allergy or eczema comes first. Medication regimen complexity and its impact on medication adherence and asthma control among patients with asthma in Ethiopian referral hospitals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1